Profit

Ranbaxy's return to US to be a long drawn process: Centrum Broking

PUBLISHED ON: September 16, 2013 | Duration: 3 min, 51 sec

facebooktwitteremailkoo
loading..
Ranjit Kapadia of Centrum Broking discusses about the import ban on Ranbaxy's Mohali factory by the US Food and Drug Administration. He says that Ranbaxy's return to the US market is going to be a lengthy process.
ALSO WATCH
Exclusive: The Cash-For-'Bail' Tapes

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com